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Critical Role for JNK in Mediating the Antagonistic Activity of TNF-a Against TGF-b/
Smad Signaling and Collagen Gene Transcription
F. Verrecchia, C. Tacheau, E. F. Wagner, and A. Mauviel
Paris, France and Vienna, Austria
Given the physiopathological importance of TGF-b and TNF-a, we have focused our attention
on the molecular events underlying their antagonistic activities regarding Smad signaling
downstream of the TGF-b receptors, and expression of type I collagen (COL1A2). Using transient
cell transfections of JNK1-JNK2 knockout (JNK±/±) and I-kBg/NEMO±/± ®broblasts, the latter
being devoid of NF-kB activity, we have determined the speci®c roles played by the Jun N-
terminal kinase (JNK)/AP-1 and NF-kB/Rel pathways in this phenomenon. We demonstrate that
neither JNK nor NF-kB activities are required for TGF-b signaling through the Smad pathway.
However, the absence of JNK activity prevents TNF-a-driven inhibition of both Smad signaling
and COL1A2 promoter transactivation by TGF-b. On the other hand, the absence of NF-kB
activity does not alter the TNF-a antagonistic effect against TGF-b. Among JNK substrates, c-Jun,
and JunB to a lesser extent, but not ATF2, antagonize TGF-b/Smad signaling. Overexpression of
JNK1 restores TNF-a/c-Jun inhibition of Smad signaling and COL1A2 promoter transactivation
by TGF-b in JNK±/± ®broblasts. Overexpression of an antisense c-jun vector or that of a dominant-
negative form of MKK4 blocks the inhibitory activity of TNF-a in NEMO±/± ®broblasts. These
results suggest a critical role for JNK-mediated c-Jun phosphorylation in mediating the inhibitory
effect of TNF-a on Smad signaling and up-regulation of type I collagen gene by TGF-b.
002
Congenital Lipodystrophy Berardinelli-Seip Reveals a New Gene and a New Protein
T. Gedde-Dahl Jr, M. DeleÂpine,* E. Khallouf,² L. Van Maldergem,³ E. Sobel,* J. Papp,* M.
Meier, A. MeÂgarbane,¶ BSCL Working Group, M. Lathrop,* J. Capeau,§ and J. MagreÂ§
Departments of Dermatology, Internal Medicine and Pediatrics, Rikshospitalet and Institute of Forensic
Medicine, University of Oslo, Oslo, Norway; *Centre National de GeÂnotypage, Evry, Paris, France;
²Service de PeÂdiatrie, HoÃtel-Dieu de France, Beyrouth; ³Centre de GeÂneÂtique Humaine, Institut de
Pathologie et de GeÂneÂtique, Loverval, Belgium; §INSERM U.402, FaculteÂ de MeÂdecine Saint-Antoine,
Paris, France; ¶UniversiteÂ Saint-Joseph, FaculteÂ de MeÂdecine, UniteÂ de GeÂneÂtique MeÂdicale, Beyrouth
The disease (BSCL) is characterized by near absence of adipose tissue from birth or early infancy,
severe insulin resistance, acanthosis nigricans, hyperandrogenism, muscular hypertrophy, hepatome-
galy, altered glucose tolerance or diabetes mellitus and hypertriglyceridemia. We have used
clustered families from Norway and Lebanon, each presumed to represent a recessive mutation
identical in descent, to reveal they both comply with genetic linkage to chromosome 11q13 DNA
markers (MagreÂ et al, 2001).
Using 25 additional dinucleotide repeat markers isolated from that segment, a 2.5 Mbase long
overlapping segment was de®ned as having absolute disease association. None of 26 structural
genes known there had detectable disease mutations. From a mouse gene (Gng3lg) of unknown
function, residing in the mouse orthologue of HSA11q13, we sequenced a new gene (BSCL2)
which appeared to have a null mutation in the Lebanon families and a missense mutation in the
Norwegian families. Moreover, of world-wide collected BSCL patients, 47 had mutations in this
gene, whereas families with patients with nonmutated BSCL2 ®tted linkage to 9q24 where a not
yet cloned gene (BSCL1) is assumed to reside (Garg et al, 1999). BSCL2 ORF is 1196 bases long
and predicts a 398 aa long peptide named seipin. The BSCL2 gene is most abundantly expressed in
CNS and in testis, but its function is unknown up to now. It is a candidate for being one of the
QTL genes for diabetes.
MagreÂ J et al: Identi®cation of the gene altered in Berardinelli-Seip congenital lipodystrophy on
chromosome 11q13. Nat Genet 28:365±370, 2001
Garg A et al: A gene for congenital generalized lipodystrophy maps to human chromosome
9q34. J Clin Endocrinol Metab 84:3390±3394, 1999
003
Effect of Vascular Endothelial Cell Growth Factor (VEGF) Deletion on Skin Biology and
Mammary Gland Development and Function
H. Rossiter,* C. Barresi,* J. Ban, C. Mayer, M. Rendl,* J. Haigh,² E. F. Wagner,² and E.
Tschachler*³
*D.I.A.I.D., Department of Dermatology, University of Vienna Medical School, Vienna, Austria; ²IMP,
Vienna, Austria; ³CE.R.I.E.S., Neuilly, France
Vascular endothelial cell growth factor (VEGF) is a major inducer of angiogenesis. In the skin, an
important source of VEGF is the epidermal keratinocyte (KC), so we wished to investigate the
contribution of KC-derived VEGF to angiogenesis-dependent processes in this organ. We have
inactivated VEGF speci®cally in mouse cells that express keratin 5, using a Cre/Lox-p system.
Deletion of exon 3 of VEGF A in genomic DNA from K5 expressing tissues was demonstrated by
PCR and Southern blotting, while cultured epidermal keratinocytes produced no detectable
VEGF. Depilation-induced anagen resulted in sparser hair regrowth and fewer hair follicles in
mutant mice, and wound healing was retarded compared to controls. Anti-CD31 staining of
wounds demonstrated a reduced microvessel density immediately below the regenerating
keratinocytes. In addition, mammary glands of lactating mutant female mice displayed signi®cantly
fewer alveolar ducts, and the weight gain of their pups was severely retarded. We thus show that
KC-derived VEGF plays an important role in epidermal wound healing and hair regrowth, while
deletion of VEGF in the mammary gland drastically compromises mammary gland development
and function.
004
The All-Trans Retinoic Acid Receptor Binds to an Element in the Promotor of Hurpin
(Proteinase Inhibitor 13, PI13) a Novel Serine Proteinase Inhibitor which is
Overexpressed in Psoriatic Skin Lesions
Tanja GuÈnther, Harry F. Abts, Carsten Carlberg,* and Thomas Ruzicka
Department of Dermatology, Heinrich-Heine University, DuÈsseldorf, Germany; *Department of
Biochemistry, University of Kuopio, Finland
Retinoic acid and vitamin D3 modulate keratinocyte proliferation and differentiation ± processes
that are disturbed in psoriatic skin ± via binding to the respective nuclear receptors for retinoic acid
(RAR-a,-g), and vitamin D3 (VDR) plus the common heterodimeric partners 9-cis-retinoic acid
receptors (RXR-a,-b). In contrast to healthy skin, in psoriatic skin lesions the serine proteinase
inhibitor hurpin (PI13) is over expressed. For those reasons it was interesting to address a potenial
regulatory in¯uence of all-trans retinoic acid (ATRA) or 1,25-dihydroxyvitamin D3 (VD),
respectively, on the hurpin promotor. RT-PCR experiments were carried out in HaCaT cells
with these ligands to address their potential in¯uence on the transcriptional activities of the hurpin
gene. The incubation with ATRA led to a strong reduction of hurpin expression to 29.8%, wheras
VD showed a repression to 63.2%. A computer based search for consensus binding sites revealed
seven potential response elements (RE) in the hurpin promotor. In performed electrophoretic
mobility shift assays, two of those potential hurpin response elements (a DR2- and a DR3-type
element) showed their binding af®nities to the receptor heterodimers RARg/RXRa and VDR/
RXRa, respectively. When ligated to a TK promotor and coupled to the pGL3 basic vector in
transient transfections, only the DR2-type element confered a 6-fold increase of luciferase activity
stimulated by ATRA, while the incubation with VD led to no effect. The VD mediated repression
of Hurpin is thus not controlled by the HP-(DR3)1-RE. These studies suggest that the repression
of hurpin mediated by ATRA on transcriptional level is correlated with the binding af®nity of the
HP-DR2-type retinoic acid RE.
005
Proteinases of Common Pathogenic Bacteria Degrade and Inactivate the Antibacterial
Peptide LL-37
A. Schmidtchen, I.-M. Frick, and L. BjoÈrck
Lund, Sweden
Effectors of the innate immunity system, the antimicrobial peptides, have pivotal roles in
preventing infection at epithelial surfaces. Here, we show that proteinases of Pseudomonas
aeruginosa, Enterococcus faecalis, and Streptococcus pyogenes degrade the antibacterial peptide LL-37.
LC-MS analysis of fragments generated by p. aeruginosa elastase revealed that the initial cleavages
occured at Asn-Leu and Phe-Leu, followed by two breaks at Arg-Ile, thus inactivating the peptide.
Proteinases of the other pathogens induced similar fragmentations as determined by SDS-PAGE.
The degradation was abolished by the metalloproteinase inhibitors GM6001, 1, 10-phenantroline
(which both inhibited P. aeruginosa elastase and E. faecalis gelatinase), or the inhibitor E64 (which
inhibited S. pyogenes cysteine proteinase). Furthermore, experiments showed that substances which
bind LL-37, such as dermatan sulphate, and disaccharides of the structure [DUA(2S)-
GalNAc(4,6S)] or sucroseoctasulfate blocked the degradation of LL-37. Thus, the degradation
of the antibacterial peptide LL-37 by bacterial proteinases represent a virulence parameter which
could be exploited in the development of novel antibacterial therapies.
006
Bone Morphogenetic Protein (BMP-1) Processes Procollagen VII to Mature Collagen
VII
A. Rattenholl, M. Koch,* D. S. Greenspan,² and L. Bruckner-Tuderman
Department of Dermatology, University of MuÈnster, Germany; *Cutaneous Biology Research Center,
MGH/Harvard Medical School, Charlestown, U.S.A.; ²Departments of Pathology and Laboratory
Medicine and Biomolecular Chemistry, University of Wisconsin, Madison, U.S.A.
Collagen VII is the major structural component of the anchoring ®brils which ensure the cohesion
between the epidermis and the dermis. This collagen is secreted by keratinocytes into the
extracellular matrix as a precursor, procollagen VII. During polymerization and maturation of the
anchoring ®brils, two procollagen VII monomers form an antiparallel homodimer with an
overlapping C-terminus, and a C-terminal propeptide is removed. However, the mechanisms of
anchoring ®bril maturation, including the cleavage site and the enzyme processing procollagen VII
have remained elusive. Genetic evidence has suggested the involvement of BMP-1 in this process,
since a naturally occurring deletion in the COL7A1 gene, 8523del14, which eliminates a a putative
cleavage site for BMP-1, prevents processing of procollagen VII in the skin. Here we show that
recombinant BMP-1 cleaves full-length human procollagen VII in vitro, yielding a cleavage
product of the same size as mature collagen VII in the dermis. In order to determine the cleavage
site, a truncated recombinant procollagen VII containing an intact C-terminus was produced. This
miniprocollagen VII was cleaved by both BMP-1 and by mammalian tolloid-like 1 (mTLL-1),
another protease of the same enzyme family. N-terminal sequencing showed that miniprocollagen
VII was processed at the predicted site. Analysis of collagen VII in the skin of BMP-1 de®cient
mouse embryos demonstrated that procollagen VII was processed to the same extent as in wild type
embryos. This suggests that in situ the collagen VII precursor can be cleaved by at least two
metalloproteases including BMP-1 and mTLL-1. The cleavage of the keratinocyte-derived
procollagen VII by ®broblast-derived enzymes presents a novel mechanism of regulation of
anchoring ®bril formation and an intriguiging manifestation of epithelial±mesenchymal
interactions.
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Serum IL-4 and Acute Phase Proteins in Patients with Mycosis Fungoides
M. Pawlaczyk and M. Sobieska PoznanÄ
Poland
The aim of the study was to investigate the acute phase proteins concentrations and glycosylation
pro®les, as well as IL-4 during various stages of mycosis fungoides (MF). Sera samples were
obtained from 45 patients with MF. Interleukin-4 concentration was determined by ELISA kit.
Proteins concentrations were measured using rocket electrophoresis. The reactivity with
Concanavalin A was estimated for alfa 1-acid glycoprotein and alfa 1-antichymotrypsin using
crossed af®nity immunoelectrophoresis. Increased concentration of IL-4 was observed in patients
with tumors and erythtoderma. C-reactive proteine was found to be elevated in about half of
subjects. The levels of alfa1-acid glycoprotein and alfa1-antichymotrypsin were increased in all
patients except those in plaque stage and the difference was statistically signi®cant. Glycosylation
pro®les were almost normal in patch stage, but in all other stages they changed towards glycoforms
weaker reacting with Concanavalin A. These results prove the involvement of both speci®c
immune reaction, concerning T-lymphocytes activation and nonspeci®c reactions, as acute phase
proteins concentration re¯ect elevated IL-6 level. Though patients suffering from MF rarely show
any abnormalities in rutine laboratory examinations from the begining of the disease, some features
of in¯ammation are present. It may be described as a generalized in¯ammatory reaction, known as
acute phase response, with the highest intensity for erythrodermic patients and lowest for patients
in plaque stage
008
Second Line Vindesine Monotherapy in Advanced Stage IV Malignant Melanoma: Low
Toxicity but no Amelioration of Disease Progression
S. Emmert, M. Zutt, H. Haenssle, C. Neumann, and L Kretschmer
Goettingen, Germany
Vindesine is a Vinca Alkaloid with mild toxicity. Anti-melanoma activity of vindesine as a single
agent as well as in polychemotherapies has been reported. We investigated the usefulness of a
second line vindesine monotherapy in stage IV melanoma. A total of 13 patients with progressive
disease were treated with 3 mg per m2 vindesine every 2 weeks (mean age 59.2 6 11.9 years).
Previous systemic treatment consisted predominantly of polychemotherapy or combined chemo-
immune therapy (seven patients received 1 treatment, three patients 2, two patients 3, and one
patient 4 treatments). All 13 patients suffered from visceral metastases besides regional skin and
lymphnode metastases (three with lung, one with liver, one with pararenal, and eight with multiple
visceral metastases). A mean of 2.7 6 1.3 vindesine treatments were administered. Only one patient
showed reversible hair loss and leucopenia. None of the patients developed neuropathy. In all of
the 13 patients (100%) vindesine treatment was stopped due to disease progression. Median survival
after ®rst diagnosis was 42 months (8±151 months), survival after entering stage IV was 11 months
(3±35 months), and survival after starting vindesine therapy was 4 months (1±22 months). We
conclude that vindesine monotherapy is ineffective in stage IV melanoma patients previously
treated with other chemotherapeutic agents.
009
Molecular Bases and Clinical-Functional Classi®cation of Ectodermal Dysplasias
M. Priolo and C. LaganaÁ
Reggio Calabria, Italy
The ectodermal dysplasias (EDs) are a large and complex nosologic group of diseases. To date, few
causative genes have been identi®ed for EDs. We recently proposed a new approach to EDs
integrating both molecular-genetic data and corresponding clinical ®ndings. This approach is the
®rst attempt to integrate both systems of classi®cation.
Two different groups are recognised, each likely to result from mutations in genes with similar
function and possibly involved in the same mechanisms of regulation of development and/or
pathogenesis. We now give an overview of molecular bases in EDs. A defect in epithelial±
mesenchymal interaction can be recognised in group one. A structural protein defect can be
recognised or postulated in group two. Finally, through an extensive revision of both molecular/
functional mechanisms and clinical presentation of very well characterised EDs, we expand this
approach to other forms speculating on possible candidate genes suggested by associated non
ectodermal features.
Many signals triggered from proteins classi®ed in the two group converge on the same
intracellular factors, interact among them or regulate each other in complex pathways. These
®ndings can explain common key signs sometimes observed in association with different types of
EDs, such as cleft lip/palate or speci®c skeletal malformations (see ectrodactyly as an example). This
approach is also a de®nitive improvement to better clarify the spatial and temporal activity of some
EDs' causative genes during development, such as the recently proved altered paracrine signalling
between EDA and EDAR when EDA can not be proteolytically cleaved by furin.
Our goal is to give both clinicians and researchers a lecture key in better understanding EDs and
in dissecting complex phenotypes. We think that the accurate de®nition of key signs associated
with the primary interest in pathogenetic processes are signi®cant supports to researchers in a
directed endeavour to ®nd new candidate ED genes.
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Preferential Usage of TCR-Vb17 by Peripheral and Cutaneous T Cells in Nickel-
Induced Contact Dermatitis
L. BuÈdinger, N. Neuser, U. Totzke, H. F. Merk, and M. Hertl
Aachen, Hamburg, and Erlangen, Germany
Nickel (Ni) is one of the most common contact sensitizers in man and Ni-induced contact
dermatitis is considered as a model of hapten-induced delayed type hypersensitivity. Previous
studies indicated that Ni-reactive T cells derived from Ni-allergic individuals preferentially express
distinct TCR-Vb chains. However, data on the TCR-Vb repertoire of Ni-responsive T cells are
not consistent. The aim of this study was therefore to identify the TCR-Vb receptors of Ni-
responsive peripheral and cutaneous T cells in a cohort of 17 donors with Ni-induced contact
dermatitis in comparison to those of 6 healthy controls. Peripheral NiSO4-responsive T
lymphocytes showed a signi®cant over-expression of TCR-Vb17 and the frequency of TCR-
Vb17 + T cells correlated signi®cantly with the in vitro reactivity of PBMC to NiSO4. In addition,
the cutaneous in®ltrate of Ni-induced patch test reactions consisted primarily of TCR-Vb17 + T
cells. The majority of patch test-derived NiSO4-responsive T cells of three allergic donors were
TCR-Vb17 + while patch test-derived NiSO4 unresponsive T cells of four additional donors did
not express TCR-Vb17. Skin-derived Ni-responsive T cell lines from three donors uniformly
secreted the Th2 cytokine, IL-5 but no IFN-g or IL-10. These in vitro and in vivo ®ndings strongly
suggest that T cells with a restricted TCR-Vb-repertoire, i.e. Vb17, predominate in NiSO4-
induced contact dermatitis and may be crucial in the effector phase of Ni hypersensitivity. Ni-
induced contact dermatitis thus holds great promise as a model system to establish therapeutic
concepts to speci®cally modulate hypersensitivity reactions against haptens such as various
ubiquitous and occupational allergens including metals, contact sensitizers, and drugs.
011
TP53 Polymorphism of Exon 4 at Codon 72 in Cutaneous Squamous Cell Carcinoma
and Benign Epithelial Lesions of Renal Transplant Recipients and Immunocompetent
Individuals: Lack of Correlation with HPV Status
O. Humbey, S. Cairey-Remonnay, C. Mougin, M. P. Algros, F. Mauny, J. Kanitakis, S. Euvrard,
R. Laurent, and F. Aubin
BesancËon and Lyon, France
Common polymorphism at codon 72 of exon 4 encoding either arginine (ARG) or proline (PRO)
has been shown to confer a susceptibility to the development of skin tumor in renal transplant
recipients (RTR). Moreover, this polymorphism may affect proteolytic degradation of p53
promoted by E6 protein from mucosal human papillomaviruses (HPV) and represent a risk factor
for HPV-induced carcinogenesis. In this study, we analyzed the HPV presence and the TP53 allele
distribution in cutaneous squamous cell carcinoma (SCC) of RTR and immunocompetent patients
(ICP). 53 SCC from 40 RTR, 50 benign epithelial skin lesions from 50 RTR with no history of
skin cancer, 51 SCC from ICP, and 29 blood samples from IC healthy individuals were
investigated. HPV DNA was detected using pcr performed with 2 pairs of primers (MY09-MY11
and FAP59-FAP64). TP53 allele distribution was studied by denaturing gradient gel electrophor-
esis assay, followed by sequencing analysis. HPV DNA was detected in 64% of SCC and 79% of
benign epithelial lesions from RTR (NS) and only in 37% of SCC from ICP (p < 0.05). Mucosal
oncogenic hpv types were predominent in SCC from both RTR and ICP. Rate of arg
homozygosity in SCC from RTR was signi®cantly higher (85%) than in ICP with or without
SCC (61% and 59%, respectively). Our results suggest that TP53 Arg/Arg genotype could
represent a potential risk factor for the development of SCC in RTR as compared to ICP.
However, no association between TP53 Arg/Arg genotype and HPV status could be determined.
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Ex Vivo Isolation and Characterization of CD4+CD25+ T Cells with Regulatory
Properties from Human Blood
D. Dieckmann, S. Berchtold, H. PloÈttner, T. Berger, and G. Schuler
Department of Dermatology, University of Erlangen-Nuremberg, Erlangen, Germany
It has been known for years that rodents harbor a unique population of CD4+CD25+
``professional'' regulatory/suppressor T cells that is crucial for the prevention of spontaneous
autoimmune diseases. Here we demonstrate that CD4+CD25+ CD45RO+ T cells (mean 6% of
CD4+ T cells) are present in the blood of adult healthy volunteers. In contrast to previous reports
these CD4+CD25+ T cells do not constitute conventional memory cells but rather regulatory cells
exhibiting properties identical to their rodent counterparts. CTLA-4 (CD152), for example, which
is essential for the in vivo suppressive activity of CD4+CD25+ T cells, was constitutively expressed,
and remained strongly up-regulated after stimulation. The cells were nonproliferative to
stimulation via their TCR, but the anergic state was partially reversed by IL-2 and IL-15. Upon
stimulation with allogeneic (but not syngeneic) mature dendritic cells or plate-bound anti
CD3 + anti-CD28 the CD4+CD25+ T cells released IL-10, and in coculture experiments
suppressed the activation and proliferation of CD4+ and CD8+ T cells. Suppression proved IL-10
independent, yet contact dependent as in the mouse. The identi®cation of regulatory CD4+CD25+
T cells has important implications for the study of tolerance in man, notably in the context of
autoimmunity, transplantation, and cancer.
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Isolation and Characterization of Dermal Lymphatic and Blood Endothelial Cells Reveal
Stable and Functionally Specialized Cell Lineages
E. Kriehuber, S. Breiteneder-Geleff, M. Groeger, A. Soleiman, S. Schoppmann, G. Stingl, D.
Kerjaschki, and D. Maurer
Vienna, Austria
Plexus of lymphatic vessels guides interstitial ¯uid, passenger leukocytes, and tumor cells towards
regional lymph nodes. Microvascular endothelial cells of lymph channels (LECs) are dif®cult to
distinguish from those of blood vessels (BECs) because both express a similar set of markers, such as
CD31, CD34, podocalyxin, von willebrand factor (vWF), etc. Analysis of the speci®c properties of
LECs was hampered so far by lack of tools to isolate LECs. Recently, the 38 kDa mucoprotein
podoplanin was found to be expressed by microvascular LECs but not BECs in vivo. Here we
isolated for the ®rst time podoplanin+ LECs and podoplanin± BECs from dermal cell suspensions
by multicolor ¯ow cytometry. Both EC types were propagated and stably expressed VE-cadherin,
CD31, and vWF. Molecules selectively displayed by LECs in vivo, i.e. Podoplanin, the hyaluronate
receptor LYVE-1, and the vascular endothelial cell growth factor (VEGF)-c receptor, Flt-4/
VEGFR-3, were strongly expressed by expanded LECs, but not BECs. Conversely, BECs but not
LECs expressed VEGF-c. LECs as well as BECs formed junctional contacts with similar molecular
composition and ultrastructural features. Nevertheless, the two EC types assembled in vascular
tubes in a strictly homotypic fashion. This EC specialization extends to the secretion of biologically
relevant chemotactic factors: LECs, but not BECs, constitutively secrete the CCR7 ligand SLC/
CCL21 at their basal side, while both subsets, upon activation, release mip-3a/CCL20 apically.
These results demonstrate that LECs and BECs constitute stable and specialized EC lineages
equipped with the potential to navigate leukocytes and, perhaps also, tumor cells into and out of
the tissues.
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Netherton Syndrome (NS) is not an Ichthyosis, but a Disease of Over-Desquamation: A
Model of Skin Barrier Dysfunction
N. Komatsu, M. Takata, N. Ohtsuki, K. Takehara, and K. Saijoh
Kanazawa, Japan
NS is a congenital ichthyosis (i.e. dry rough skin resembling ®sh scale) associated with
erhthroderma, hair-shaft defects and atopic features. Although the mutations of the secretory serine
protease inhibitor Kazal-type 5 (SPINK5) gene have recently been identi®ed in NS patients, how
the genetic defects cause characteristic skin phenotype is unknown. Here we propose a model of
inhibitory regulation of corneocyte desquamation by a set of peptides encoded by the SPINK5
gene. The SPINK5 gene encodes a proprotein which possesses multiple potential cleavage sites for
a family of subtilisin-like proprotein convertases and carboxypeptidases and is subjected to limited
proteolysis. The cleaved peptides inhibit serine proteases activated in the super®cial stratum
corneum that play a critical role in the corneocyte desquamation by degrading intercellular
desmoglein-1. The defective inhibitory regulation of SPINK5-derived peptides in NS patients
results in increased protease activity in the super®cial stratum corneum leading to over-
desquamation of corneocytes. This hypothesis is supported by a distinct phenotype-genotype
correlation and the markedly increased stratum corneum hydrolytic activity in 3 NS patients from
2 unrelated Japanese families. Therefore, NS is not an ichthyosis, but a disease of over-
desquamation causing severe skin permeability barrier dysfunction.
015
Vivo Phenotypic Reversion of Recessive Dystrophic Epidermolysis Bullosa
Keratinocytes
C. Baldeschi, Y. Gache, A. Rattenholl,* L. Bruckner-Tuderman,* J. P. Ortonne, and G.
Meneguzzi
INSERM U385, FaculteÂ de MeÂdecine, Nice, France; *Department of Dermatology, University of Muenster,
Germany
Dystrophic epidermolysis bullosa (DEB) is an inherited skin disorder caused by mutations in
collagen type VII, the major component of the anchoring ®brils of the dermal-epidermal junction.
Gene therapy of DEB is justi®ed because no other treatment is available. However, the size of the
collagen VII cDNAs (> 9 kb) and the risk of immune response against the transgene product are
serious hurdles. The identi®cation of inbred dogs suffering from recessive DEB caused by
expression of an abnormal collagen type VII gene offers the possibility of testing therapeutic assays
based on gene replacement in immunocompetent hosts. Screening for genetic mutations in the
affected animals detected a homozygous nucleotide change (5716G®A) in the Col7A1 gene that
cosegregates with the recessive DEB phenotype. The sequence variation predicts the substitution
of a glycine residue (1906G®S) within the collagenous domain of the polypeptide. To perform a
phenotypic reversion of recessive DEB keratinocytes, we have isolated and characterized the
canine collagen type VII full-length cDNA from a wild type dog. The full-length cDNA was
transfected ex vivo into immortalized and primary human collagen VII-null keratinocytes and
®broblasts using a panel of retroviral vectors. All the recombinant viruses ef®ciently expressed the
canine collagen type VII molecules. The transduced keratinocytes synthesized pro-collagen VII
molecules of the expected size that display the subcellular distribution and secretion pattern
observed in normal human keratinocytes. The reverted keratinocytes also displayed decreased rates
of proliferation and reduced motility. The reverted cells sustain expression of the collagen type VII
transgene for at least four months in culture. These results demonstrate that retroviral vectors are
promising tools for gene therapy of recessive DEB and for the functional analysis of the different
domains of collagen type VII by site-directed mutagenesis of the corresponding cDNA
016
Targeted Ablation of the Murine LAMC2 Gene Recapitulates Human Herlitz Junctional
Epidermolysis Bullosa Phenotype
J. Uitto, X. Meng, J. Klement, and L. Pulkkinen
Jefferson Medical College, Philadelphia, Pennsylvania, U.S.A.
The Herlitz junctional epidermolysis bullosa (H-JEB) is an autosomal recessive blistering disorder
with poor prognosis. The underlying mutations reside in the genes encoding laminin 5 subunit
polypeptides, most of them in LAMB3 (b3 chain) while some have been described in LAMA3 and
LAMC2 (a3 and g2 chains). To evaluate the pathomechanisms and tissue involvement of H-JEB in
further detail, and to provide an animal model for development of gene therapy approaches, we
have developed a LAMC2 null mouse (±/±) by targeted ablation of exon 8 of the g2 chain gene of
laminin 5, which results in out-of-frame deletion of 115 bp and creates a downstream premature
termination codon for translation. Heterozygous mice were clinically normal, while homozygotes
manifested with extensive blistering of the skin and mucous membranes and died within 1±2 day of
birth. Histopathology revealed tissue separation at the cutaneous basement membrane zone.
Immunohistochemistry of the skin and tongue at the dermal-epidermal junction (DEJ) was
essentially negative for g2 chain expression, and a3 chain expression was concomitantly reduced.
The expression of other DEJ components (type VII and XVII collagens, a6 integrin, and plectin)
appeared normal. RT-PCR clearly detected the shortened mRNA transcript in ±/± mice, but
Western analysis was unable to detect g2 chains. PCR genotyping revealed that in 21 litters, 41
(24.4%), 96 (57.1%), and 31 (18.5%) mice were ±/±, +/±, and +/+, respectively, consistent with
autosomal recessive inheritance and no evidence for embryonic lethality. Collectively, these data,
together with previously developed LAMA3 ±/± mice and a naturally occurring LAMB3 null
mouse, attest to the critical importance of each laminin 5 polypeptide subunit in epithelial-
mesenchymal adhesion.
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